OXTRIPHYLLINE Drug Patent Profile
✉ Email this page to a colleague
When do Oxtriphylline patents expire, and when can generic versions of Oxtriphylline launch?
Oxtriphylline is a drug marketed by Morton Grove and Watson Labs and is included in four NDAs.
The generic ingredient in OXTRIPHYLLINE is oxtriphylline. There are three drug master file entries for this compound. Additional details are available on the oxtriphylline profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXTRIPHYLLINE?
- What are the global sales for OXTRIPHYLLINE?
- What is Average Wholesale Price for OXTRIPHYLLINE?
Summary for OXTRIPHYLLINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Patent Applications: | 2,913 |
| DailyMed Link: | OXTRIPHYLLINE at DailyMed |
US Patents and Regulatory Information for OXTRIPHYLLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morton Grove | OXTRIPHYLLINE | oxtriphylline | SOLUTION;ORAL | 088243-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Morton Grove | OXTRIPHYLLINE PEDIATRIC | oxtriphylline | SYRUP;ORAL | 088242-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | OXTRIPHYLLINE | oxtriphylline | TABLET, DELAYED RELEASE;ORAL | 087866-001 | Aug 25, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | OXTRIPHYLLINE | oxtriphylline | TABLET, DELAYED RELEASE;ORAL | 087835-001 | Aug 25, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
